Donating is simple, fast and totally secure. Your details are safe with us and we will never sell them
Pancreatic Neuroendocrine Tumours (pNET) are increasing in incidence(1), (2). They carry a relatively poor prognosis compared to other NETs, particularly when hepatic metastasis are present. We have a proactive management strategy that is agreed in a weekly NET MDT. We have studied our outcomes and determined survival at 1, 3 & 5 years and compared our outcomes to previously published data. The data is on our whole cohort not on selected treatments and irrespective of age, fitness, age or co-morbidities. Click on the link below for full presentation.
Diseases we treat
How the money raised is spent
See all stories